Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid versus hydroquinone for melasma
IRCT20180909040979N5Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tranexamic acid and hydroquinone in melasma (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Degree of melasma treatment. Started Dec 2019; status: completed.
02
Drugs
tranexamic acidhydroquinone
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20180909040979N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180909040979N5.